PPARG and colitis: In addition, the same studies in OXA-induced colitis mice indicated that treatment with Tetramethylpyrazine could improve the outcome of intestinal inflammation via PPARγ signaling-mediated inhibition of NF-kB signaling (Lu et al., 2014).